Category: Supplier News

Creating a compelling mission and set of values

Xellia Pharmaceuticals is a speciality pharmaceutical company based in Denmark that develops anti-infective treatments against bacterial, fungal and antibiotic-resistant infections.  Xellia is owned by Novo A/S. Carl-Åke Carlsson, CEO explains the reasons why Xellia re-shaped their organisational and culture and why they chose to work with Mark at Co-create. The challenge Over the recent period…